You can buy or sell AQXP and other stocks, options, ETFs, and crypto commission-free!
Aquinox Pharmaceuticals, Inc. Common Stock, also called Aquinox Pharmaceuticals, is a clinical-stage pharmaceutical company. Read More It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada.
Vancouver, British Columbia
52 Week High
52 Week Low
Yahoo FinanceApr 26
What Kind Of Shareholder Appears On The Aquinox Pharmaceuticals, Inc.'s (NASDAQ:AQXP) Shareholder Register?
The big shareholder groups in Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Companies that have been privatized tend to have low insider ownership. Aquinox Pharmaceuticals is a smaller company with a market capitalization of US$64m, so it may still be flying under the radar of many institutional investors. In the chart below below, we can see that institution...
-$0.05 per share
Expected May 29, Pre-Market